MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.hrthm.2022.03.1226

Медицинская библиотека · Heart rhythm · 2022

Clinical outcomes and predictors of complications in patients undergoing leadless pacemaker implantation.

Haddadin Faris, Majmundar Monil, Jabri Ahmad, Pecha Luke, Scott Claire, Daher Marilyne, Kumar Ashish, Kalra Ankur, Fram Rand, Haddadin Farah, Almahameed Soufian, DeSimone Christopher V, Cha Yong-Mei, Mulpuru Siva K, Ellenbogen Kenneth A, Saeed Mohammad, Chelu Mihail G, Deshmukh Abhishek J

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Leadless pacemakers have emerged as a viable alternative for traditional transvenous pacemakers to reduce the risk of device-related complications.

OBJECTIVE

The purpose of this study was to examine the real-world clinical outcomes and complications associated with the implantation of leadless pacemaker devices.

METHODS

Using the National Readmission Database (NRD), we examined patient demographics, and in-hospital and 30-day procedural outcomes after leadless pacemaker implantation from 2016-2018. Our cohort comprised adults (≥18 years) with an ICD-10 procedural code for leadless pacemaker implantation.

RESULTS

Our cohort included a total of 7821 patients who underwent leadless pacemaker implantation. Overall immediate procedure-related complications, as defined broadly in this study, occurred in 7.5% of patients. Pericardial effusion without the need for pericardiocentesis occurred in 1.9% of patients, with pericardiocentesis performed in 1.0%. Vascular complications occurred in 2.3% of patients; 0.33% required repair, and device dislodgment occurred in 0.51%. The most significant predictor for procedural complications was end-stage renal disease (odds ratio [OR] 1.65; 95% confidence interval [CI] 1.17-2.32; P = .004), congestive heart failure (OR 1.28; 95% CI 1.01-1.62; P = .04), and coagulopathy (OR 1.77; 95% CI 1.34-2.34; P <.001). All-cause readmission occurred in 17.9% of patients within 30 days from device implant, with 1.36% of readmissions being procedure related. At 30 days postimplant and after discharge, 0.25% of patients needed a new pacemaker, and 0.18% had pericardial complications.

CONCLUSION

In our large real-life cohort, we found the rate of serious complications after leadless pacemaker implantation to be relatively low and comparable to prior studies in a high-risk population with multiple comorbid conditions.

Для цитирования: Haddadin Faris, Majmundar Monil, Jabri Ahmad, Pecha Luke, Scott Claire, Daher Marilyne, Kumar Ashish, Kalra Ankur, Fram Rand, Haddadin Farah, Almahameed Soufian, DeSimone Christopher V, Cha Yong-Mei, Mulpuru Siva K, Ellenbogen Kenneth A, Saeed Mohammad, Chelu Mihail G, Deshmukh Abhishek J. Clinical outcomes and predictors of complications in patients undergoing leadless pacemaker implantation.. Heart rhythm. 2022. DOI: 10.1016/j.hrthm.2022.03.1226.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.